Core Scientific, Inc. CORZ
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$13.24$14.16
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 486.01M | 289.07M | 162.61M | 89.81M | 67.24M |
| Total Other Revenue | 106.07M | 151.24M | 192.13M | 229.21M | 266.94M |
| Total Revenue | 592.07M | 440.31M | 354.74M | 319.02M | 334.18M |
| Cost of Revenue | 331.21M | 298.81M | 278.26M | 264.43M | 299.66M |
| Gross Profit | 260.87M | 141.50M | 76.48M | 54.59M | 34.52M |
| SG&A Expenses | 189.39M | 191.89M | 186.82M | 177.49M | 181.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 58.33M | 66.64M | 27.47M | 31.60M | -26.50M |
| Total Operating Expenses | 578.93M | 557.34M | 492.55M | 473.52M | 454.73M |
| Operating Income | 13.14M | -117.03M | -137.82M | -154.50M | -120.55M |
| Income Before Tax | -214.12M | -1.43B | -1.21B | -289.84M | -892.12M |
| Income Tax Expenses | -103.90M | 2.73M | 978.00K | 583.00K | 863.00K |
| Earnings from Continuing Operations | -110.22 | -1.43K | -1.21K | -290.43 | -892.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -110.22M | -1.43B | -1.21B | -290.43M | -892.99M |
| EBIT | 13.14M | -117.03M | -137.82M | -154.50M | -120.55M |
| EBITDA | 77.37M | -54.46M | -71.99M | -85.59M | -39.69M |
| EPS Basic | -0.37 | -4.25 | -1.77 | -0.89 | -2.49 |
| Normalized Basic EPS | 0.39 | -1.92 | -1.66 | -0.40 | -1.44 |
| EPS Diluted | -3.51 | -4.43 | -1.95 | -1.08 | -2.49 |
| Normalized Diluted EPS | -0.39 | -2.08 | -1.82 | -0.57 | -1.44 |
| Average Basic Shares Outstanding | 1.30B | 1.29B | 1.28B | 1.27B | 1.26B |
| Average Diluted Shares Outstanding | 1.58B | 1.43B | 1.42B | 1.42B | 1.26B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |